Our previous studies have demonstrated that CXCL16 signaling through CXCR6 may contribute to prostate cancer progression by serving as a proliferative signal and as a regulator of invasion [11, 36]; however, its role and mechanism of in BC development is still kept unsettled. This evidence concerns the gene CXCL16 and prostate carcinoma.